Abstract
Immunolocalization of aromatase can provide important information about the status of intratumoral aromatase of human breast. We have performed immunohistochemistry of aromatase in surgical pathology specimens of human breast disorders using monoclonal and polyclonal antibodies. Both antibodies yielded satisfactory results in immunostaining of aromatase in normal placenta and normal cycling human ovaries. In human breast disorders, immunostaining or aromatase using monoclonal antibodies can only demonstrate immunoreactivity following antigen retrieval. Immunoreactivity can be detected in both carcinoma and stromal cells but nuclear immunoreactivity, which may be represent artefactural changes, can be detected in both normal and neoplastic breasts. Immunostaining using polyclonal antibody revealed aromatase immunoreactivity in cytoplasm of adipocytes, fibroblasts, vascular wall cells and Schwann cells but intense immunoreactivity was detected in adipocytes adjacent to carcinoma invasion in 68/82 carcinoma cases and stromal cells around carcinoma nest in 58/82 cases. Strong aromatase immunoreactivity was detected in 7/69 benign proliferative breast disorder, 5 of which were sclerosing adenosis. Aromatase immunoreactivity was also detected in carcinoma cells in 7/82 cases but aromatase positive carcinoma cells represent less than 5% of tumor cells in all these cases. These results above indicate that polyclonal antibody is considered to be more suitable for aromatase immunohistochemistry in archival materials of breast disorders but further investigations including easy and reproducible scoring system and production of reliable monoclonal antibodies are required to establish aromatase immunohistochemistry as a reliable method of assessing intratumoral aromatase in human breast disorders.
Similar content being viewed by others
References
Miller WR, Forrest APM: Oestradiol synthesis from C19 steroids by human breast cancer. Br J Cancer 33: 905–911, 1974
Miller WR, Hawkins RA, Forrest APM: Significance of aromatase activity in human breast cancer. Cancer Res 42: 3365–3368, 1982
Sasano H, Nagura H, Harada N, Goukon Y, Kimura M: Immunolocalization of aromatase and other steroidogenic enzymes in human breast disorders. Hum Pathol 25: 530–535. 1994
Bulun SE, Simpson ER: Regulation of aromatase expression in human tissues. Breast Cancer Treat 30: 19–29, 1994
Sasano H, Okamoto M, Mason JI, Simpson ER, Mendelson CR, Sasano N, Silverberg SG: Immunolocalization of aromatase, 17α-hydroxylase and side-chain-cleavage cytochromes P450 in the human ovary. J Reprod Fert 85: 163–169, 1989
Nakazumi H, Sasano H, Maehara I, Ozaki M, Tezuka F, Orikasa S: Estrogen metabolism and impaired spermatogenesis in germ cell tumors of the testis. J Clin Endocrinol Metab 81: 1289–1295, 1996
Esteban JM, Warsi Z, Haniu M, Chen S: Detection of intratumoral aromatase in breast carcinoma. An immunohistochemical study with clinicopathologic correlation. Am J Pathol 940: 337–343, 1992
Sasano H, Okamoto M, Mason JI, Simpson ER, Mendelson CR, Sasano N, Silverberg SG: Immunohistochemical studies of steroidogenic enzymes (aromatase, 17α-hydroxylase and cholesterol side-chain cleavage cytochromes P-450) in sex cord stromal tumors of the ovary. Hum Pathol 20: 452–457, 1989
Sasano H: Functional pathology of human ovarian steroidogenesis: Normal cycling ovary and steroid-producing ncoplasms. Endocr Pathol 5: 81–89, 1994
Sasano H, Frost AR, Saitoh R, Harada N, Poutanen M, Vihko R, Bulun SE, Silverberg SG, Nagura H: Aromatase and 17β-hydroxysteroid dehydrogenase type 1 in human breast carcinoma. J Clin Endocrinol Metab 81: 4042–4246, 1996
Sasano H, Kimura M, Shizawa S, Kimura N, Nagura H: Aromatase and steroid receptors in gynecomastia and male breast carcinoma: An immunohistochemical study. J Clin Endocrinol Metab 81: 3063–3067, 1996
Santner SJ, Pauley RJ, Tait L, Kaseta J, Santen RJ: Aromatase activity and expression in breast cancer and benign breast tissue stromal cells. J Clin Endocrinol Metab 82: 200–208, 1997
Lu Q, Nakamura J, Savinov A, Yue W, Weisz J, Dabbs DJ, Wolz G, Brodie A: Expression of aromatase protein and messenger ribonucleic acid in tumor epithelial cells devidence of functional significance of locally produced estrogen in human breast cancers. Endocrinology 137: 3061–3068, 1996
Santen RJ, Martel J, Hoagland M: Stromal spindle cells contain aromatase in human breast tumors. J Clin Endocrinol Metab 79: 627–632, 1994
Mendelson CR, Wright EE, Evans CT, Porter JC, Simpson ER: Preparation and characterization of polyclonal and monoclonal antibodies against human aromatase cytochrome P-450 (P-450arom) and their use in its purification. Arch Biochem Biophys 243: 480–491, 1985
Harada N: Novel properties of human placental aromatase as cytochrome P450: Purification and characterization of a unique form of aromatase. J Biochem 103: 106–112, 1988
Sasano H, Kaga K, Sato S, Yajima A, Nagura H: Adrenal 4-binding protein in common epithelial and metastatic tumors of the ovary. Hum Pathol 27: 595–598, 1996
Suzuki T, Sasano H, Sasaki H, Fukaya T, Nagura H: Ouantitation of P450 aromatase immunoreactivity in human ovary during the menstrual cycle: relationship between the enzymes activity and immunointensity. J Histochem Cytochem 42: 1565–1573, 1994
Kage K, Sasano H, Harada N, Ozaki M, Sato S, Yajima A: Aromatase in human epithelial ovarian neoplasms. Am J Pathol 149: 45–51, 1996
Watanabe K, Sasano H, Harada N, Ozaki M, Niikura H, Sato S, Yajima A: Aromatase in human endometrial carcinoma an hyperplasia: immunohistochemical, in situ hybridization, and biochemical studies. Am J Pathol 146: 491–500, 1995
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sasano, H., Murakami, H. Immunolocalization of aromatase in human breast disorders using different antibodies. Breast Cancer Res Treat 49 (Suppl 1), S79–S84 (1998). https://doi.org/10.1023/A:1006009128920
Issue Date:
DOI: https://doi.org/10.1023/A:1006009128920